TITLE

New allergy relief, over the counter

AUTHOR(S)
Watson, Traci; Wiener, Leonard
PUB. DATE
January 1997
SOURCE
U.S. News & World Report;1/20/97, Vol. 122 Issue 2, p70
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports the US Food and Drug Administration approved, in January 1997, the over-the-counter use of cromolyn sodium. The drug, called Nasalcrom, as the first over-the-counter drug than can both treat and prevent symptoms of allergic rhinitis; How to use the drug for best effect; Limitations of the drug; Availability date.
ACCESSION #
9701150331

 

Related Articles

  • Bronchodilator effect of sodium cromoglycate and its clinical implications. Chung, J.T.N.; Jones, R.S. // British Medical Journal;10/27/1979, Vol. 2 Issue 6197, p1033 

    Examines the efficacy of sodium cromoglycate (SCG) for the treatment of children with asthma. Comparison between SCG and salbutamol with placebo; Measurement of peak expiratory flow rate before exercise; Evaluation of the bronchodilator action of SCG.

  • Sodium cromoglycate in proctitis and ulcerative colitis. Allan, R.N. // British Medical Journal (Clinical Research Edition);1/9/1982, Vol. 284 Issue 6309, p70 

    Investigates the efficacy of sodium cromoglycate in treating symptomatic proctitis and ulcerative colitis. Association between sodium cromoglycate and improved sigmoidoscopic and rectal biopsy arrangements; Confirmation of the relapse rate; Effectiveness of desensitization.

  • New treatment for ulcerative colitis?  // British Medical Journal;1/3/1976, Vol. 1 Issue 6000, p2 

    Examines the latest treatment for ulcerative colitis. Relation of ulcerative proctitis to ulcerative colitis; Usefulness of disodium cromoglycate (DSCG) in treating the disease; Effect of using the DSCG and the double-blind crossover method.

  • Prescription nasal spray specifically OK'd for OTC allergy...  // FDA Consumer;Apr97, Vol. 31 Issue 3, p5 

    Focuses on Nasalcrom, a nasal spray approved by the Food and Drug Administration for preventing and treating nasal allergy symptoms. Prescription on the use of the spray; Drugs to be use in conjunction with Nasalcrom in the first part of the therapy; Side effects of the drug.

  • Choosing Therapy for Childhood Asthma. Holgate, Stephen T.; Frew, Anthony J. // New England Journal of Medicine;12/04/97, Vol. 337 Issue 23, p1690 

    Editorial. Focuses on choosing a therapy for childhood asthma. The availability of inhaled corticosteroids, cromolyn sodium or nedocromil sodium, beclomethasone dipropionate and salmeterol; Other options, such as environmental interventions; Reference to work by Simons et al in same issue.

  • Oral Disodium Cromoglycate Treatment on Irritable Bowel Syndrome: An Open Study on 101 Subjects with Diarrheic Type. Stefanini, G. F.; Prati, E.; Albini, M. C.; Piccinini, G.; Capelli, S.; Castelli, E.; Mazzetti, M.; Gasbarrini, G. // American Journal of Gastroenterology;Jan1992, Vol. 87 Issue 1, p55 

    Several studies on the usefulness of oral disodium cromoglycate (DSCG) in the treatment of systemic adverse reaction to foods have been performed, with less attention to gastroenterological symptoms. In the present study, we selected 101 patients with diarrhetic-type irritable bowel syndrome...

  • RESPIRATORY TRACT.  // MPR - Residents' Edition;Spring/Summer2009, Vol. 18 Issue 1, p210 

    The article offers information on drug prescription for asthma. It states that while asthma is a classified as a chronic inflammatory disorder of the airways, patients should start treatment at a higher step in order to achieve rapid control while stepping down to the minimum therapy. Further,...

  • Double blind cross over trial of ipratropium and placebo in chronic rhinorrhoea. von Haacke, N.P.; Moore-Gillon, V.; Capel, L.H. // British Medical Journal (Clinical Research Edition);10/29/1983, Vol. 287 Issue 6401, p1258 

    Examines the cause of watery rhinorrhea in patients with perennial rhinitis. Treatment with topical beclomethasone diproprionate and disodium cromoglycate; Efficiency of antihistamines; Assessment on patients with chronic watery rhinorrhea.

  • Preventive effect of 2 and 10 mg of sodium cromoglycate on exercise-induced bronchoconstriction. Storm van's Gravesande, Karin; Mattes, Jörg; Großklauß, Elke; Zurmühl, Andreas; Moseler, Michael; Kühr, Joachim // European Journal of Pediatrics;2000, Vol. 159 Issue 10, p759 

    Abstract This double-blind, randomised and cross-over study was designed to compare the preventive effect against exercise-induced bronchoconstriction (EIB), defined as the percentage decrease in FEV[sub 1] is greater than or equal to 15% after 6 min of exercise, of 2 mg and 10 mg of sodium...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics